Short answer
Quantum-Si Inc (QSI) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Proteus development program detected all 20 naturally occurring amino acids.
Quantum-Si Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Proteus development program detected all 20 naturally occurring amino acids
- Technical milestone supports Quantum-Si’s progress toward broader protein sequencing capabilities
- Commercial readiness, timing and financial impact remain dependent on further development and validation
Item EX-99.1 · Exhibit EX-99.1
- Proteus demonstrated single-molecule detection of all 20 amino acids, achieving QSI’s year-end 2026 goal ahead of schedule
- Technical milestone establishes complete amino acid detection as a potential benchmark for protein sequencing
- Reference-free protein identification and expanded proteoform analysis could broaden Proteus’s addressable market
- QSI is incorporating 20-amino-acid detection into a developmental sequencing kit, with commercial launch still dependent on validation and manufacturing readiness
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quantum-Si Inc 8-K filings
Get the next QSI 8-K as it lands
Follow QSI for push alerts, or ask the research agent what this filing means.